Infiltrative non-mass-like hepatocellular carcinoma initially presenting with isolated malignant portal vein thrombosis: A case report and review of the literature
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394–424.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA:Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2018;68:394–424.10.3322/caac.2149230207593Search in Google Scholar
Budny A, Kozłowski P, Kamińska M, Jankiewicz M, Kolak A, Budny B et al.: [Epidemiology and risk factors of hepatocellular carcinoma]. Pol Merkur Lekarski 2017; 43: 133–139.BudnyAKozłowskiPKamińskaMJankiewiczMKolakABudnyB:[Epidemiology and risk factors of hepatocellular carcinoma].2017;43:133–139.Search in Google Scholar
Jindal A, Thadi A, Shailubhai K: Hepatocellular carcinoma: etiology and current and future drugs. J Clin Exp Hepatol 2019; 9: 221–232.JindalAThadiAShailubhaiK:Hepatocellular carcinoma: etiology and current and future drugs.2019;9:221–232.10.1016/j.jceh.2019.01.004647712531024205Search in Google Scholar
Fujiwara N, Friedman SL, Goossens N, Hoshida Y: Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol 2018; 68: 526–549.FujiwaraNFriedmanSLGoossensNHoshidaY:Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.2018;68:526–549.10.1016/j.jhep.2017.09.016581831528989095Search in Google Scholar
Society AC: Liver cancer risk factors 2019 [updated April 1, 2019. Online: https://www.cancer.org/cancer/liver-cancer/causes-risks-prevention/risk-factors.html].SocietyAC:2019[updated April 1, 2019. Online: https://www.cancer.org/cancer/liver-cancer/causes-risks-prevention/risk-factors.html].Search in Google Scholar
Shafizadeh N, Kakar S: Hepatocellular carcinoma: histologic subtypes. Surg Pathol Clin 2013; 6: 367–384.ShafizadehNKakarS:Hepatocellular carcinoma: histologic subtypes.2013;6:367–384.10.1016/j.path.2013.03.00726838979Search in Google Scholar
El Jabbour T, Lagana SM, Lee H: Update on hepatocellular carcinoma: Pathologists’ review. World J Gastroenterol 2019; 25: 1653–1665.El JabbourTLaganaSMLeeH:Update on hepatocellular carcinoma: Pathologists’ review.2019;25:1653–1665.10.3748/wjg.v25.i14.1653646594331011252Search in Google Scholar
Torbenson MS: Morphologic subtypes of hepatocellular carcinoma. Gastroenterol Clin North Am 2017; 46: 365–391.TorbensonMS:Morphologic subtypes of hepatocellular carcinoma.2017;46:365–391.10.1016/j.gtc.2017.01.00928506370Search in Google Scholar
Han YS, Choi DL, Park JB: Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation – eighteen months of followup: a case report. Transplant Proc 2008; 40: 2835–2836.HanYSChoiDLParkJB:Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation – eighteen months of followup: a case report.2008;40:2835–2836.10.1016/j.transproceed.2008.07.01218929876Search in Google Scholar
Okuda K, Noguchi T, Kubo Y, Shimokawa Y, Kojiro M, Nakashima T: A clinical and pathological study of diffuse type hepatocellular carcinoma. Liver 1981; 1: 280–289.OkudaKNoguchiTKuboYShimokawaYKojiroMNakashimaT:A clinical and pathological study of diffuse type hepatocellular carcinoma.1981;1:280–289.10.1111/j.1600-0676.1981.tb00044.x6294441Search in Google Scholar
Kim YK, Han YM, Kim CS: Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. Eur J Radiol 2009; 70: 94–100.KimYKHanYMKimCS:Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI.2009;70:94–100.10.1016/j.ejrad.2008.01.01518316169Search in Google Scholar
Rogoveanu I, Văcaru D, Gheonea D, Georgescu CV, Comănescu V, Ciurea T: Diagnostic particularities in primitive diffuse form hepatocellular carcinoma associated with portal vein thrombosis. Rom J Morphol Embryol 2005; 46: 317–321.RogoveanuIVăcaruDGheoneaDGeorgescuCVComănescuVCiureaT:Diagnostic particularities in primitive diffuse form hepatocellular carcinoma associated with portal vein thrombosis.2005;46:317–321.Search in Google Scholar
Jakate S, Yabes A, Giusto D, Naini B, Lassman C, Yeh MM et al.: Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis. Am J Surg Pathol 2010; 34: 935–341.JakateSYabesAGiustoDNainiBLassmanCYehMM:Diffuse cirrhosis-like hepatocellular carcinoma: a clinically and radiographically undetected variant mimicking cirrhosis.2010;34:935–341.10.1097/PAS.0b013e3181ddf52f20463569Search in Google Scholar
Ho CM, Liang PC, Hu RH, Lee PH: Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection. Surgery 2016; 160: 519–520.HoCMLiangPCHuRHLeePH:Diffuse cirrhosis-like recurrence of hepatocellular carcinoma after curative resection.2016;160:519–520.10.1016/j.surg.2015.12.007Search in Google Scholar
Poddar N, Avezbakiyev B, He Z, Jiang M, Gohari A, Wang JC: Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis. J Gastrointest Cancer 2012; 43: 486–489.PoddarNAvezbakiyevBHeZJiangMGohariAWangJC:Hepatocellular carcinoma presenting as an incidental isolated malignant portal vein thrombosis.2012;43:486–489.10.1007/s12029-010-9235-zSearch in Google Scholar
Trevisani F, Caraceni P, Bernardi M, D’Intino PE, Arienti V, Amorati P et al.: Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993; 72: 1557–1563.TrevisaniFCaraceniPBernardiMD’IntinoPEArientiVAmoratiP:Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors.1993;72:1557–1563.10.1002/1097-0142(19930901)72:5<1557::AID-CNCR2820720512>3.0.CO;2-5Search in Google Scholar
Kanematsu M, Semelka RC, Leonardou P, Mastropasqua M, Lee JK: Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations. J Magn Reson Imaging 2003; 18: 189–195.KanematsuMSemelkaRCLeonardouPMastropasquaMLeeJK:Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.2003;18:189–195.10.1002/jmri.10336Search in Google Scholar
Reynolds AR, Furlan A, Fetzer DT, Sasatomi E, Borhani AA, Heller MT et al.: Infiltrative hepatocellular carcinoma: what radiologists need to know. Radiographics 2015; 35: 371–386.ReynoldsARFurlanAFetzerDTSasatomiEBorhaniAAHellerMT:Infiltrative hepatocellular carcinoma: what radiologists need to know.2015;35:371–386.10.1148/rg.352140114Search in Google Scholar
Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR et al.: Infiltrating hepatocellular carcinoma: seeing the tree through the forest. J Gastrointest Surg 2011; 15: 2089–2097.DemirjianAPengPGeschwindJFCosgroveDSchutzJKamelIR:Infiltrating hepatocellular carcinoma: seeing the tree through the forest.2011;15:2089–2097.10.1007/s11605-011-1614-7Search in Google Scholar
Sereni CP, Rodgers SK, Kirby CL, Goykhman I: Portal vein thrombus and infiltrative HCC: a pictoral review. Abdom Radiol (NY) 2017; 42: 159–170.SereniCPRodgersSKKirbyCLGoykhmanI:Portal vein thrombus and infiltrative HCC: a pictoral review.2017;42:159–170.10.1007/s00261-016-0855-zSearch in Google Scholar
Benvegnù L, Noventa F, Bernardinello E, Pontisso P, Gatta A, Alberti A: Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development. Gut 2001; 48: 110–115.BenvegnùLNoventaFBernardinelloEPontissoPGattaAAlbertiA:Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development.2001;48:110–115.10.1136/gut.48.1.110Search in Google Scholar
Myung SJ, Yoon JH, Kim KM, Gwak GY, Kim YJ, Yu JW et al.: Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments. Hepatogastroenterology 2006; 53: 266–270.MyungSJYoonJHKimKMGwakGYKimYJYuJW:Diffuse infiltrative hepatocellular carcinomas in a hepatitis B-endemic area: diagnostic and therapeutic impediments.2006;53:266–270.Search in Google Scholar
Kneuertz PJ, Demirjian A, Firoozmand A, Corona-Villalobos C, Bhagat N, Herman J et al.: Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes. Ann Surg Oncol 2012; 19: 2897–2907.KneuertzPJDemirjianAFiroozmandACorona-VillalobosCBhagatNHermanJ:Diffuse infiltrative hepatocellular carcinoma: assessment of presentation, treatment, and outcomes.2012;19:2897–2907.10.1245/s10434-012-2336-0Search in Google Scholar
Farinati F, Marino D, De Giorgio M, Baldan A, Cantarini M, Cursaro C et al.: Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol 2006; 101: 524–532.FarinatiFMarinoDDe GiorgioMBaldanACantariniMCursaroC:Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither?2006;101:524–532.10.1111/j.1572-0241.2006.00443.xSearch in Google Scholar
Tada T, Kumada T, Toyoda H, Kiriyama S, Sone Y, Tanikawa M et al.: Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma. Liver Int 2005; 25: 848–853.TadaTKumadaTToyodaHKiriyamaSSoneYTanikawaM:Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.2005;25:848–853.10.1111/j.1478-3231.2005.01111.x15998436Search in Google Scholar
Okuda H, Saito A, Shiratori K, Yamamoto M, Takasaki K, Nakano M: Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3. J Gastroenterol Hepatol 2005; 20: 759–764.OkudaHSaitoAShiratoriKYamamotoMTakasakiKNakanoM:Clinicopathologic features of patients with primary malignant hepatic tumors seropositive for alpha-fetoprotein-L3 alone in comparison with other patients seropositive for alpha-fetoprotein-L3.2005;20:759–764.10.1111/j.1440-1746.2005.03773.x15853991Search in Google Scholar
Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M et al.: Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol 2002; 17: 772–778.OkudaHNakanishiTTakatsuKSaitoAHayashiNYamamotoM:Clinicopathologic features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein-L3 and seronegative for des-gamma-carboxy prothrombin in comparison with those seropositive for des-gamma-carboxy prothrombin alone.2002;17:772–778.10.1046/j.1440-1746.2002.02806.x12121507Search in Google Scholar
Yu NC, Chaudhari V, Raman SS, Lassman C, Tong MJ, Busuttil RW et al.: CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis. Clin Gastroenterol Hepatol 2011; 9: 161–167.YuNCChaudhariVRamanSSLassmanCTongMJBusuttilRW:CT and MRI improve detection of hepatocellular carcinoma, compared with ultrasound alone, in patients with cirrhosis.2011;9:161–167.10.1016/j.cgh.2010.09.01720920597Search in Google Scholar
Lim S, Kim YK, Park HJ, Lee WJ, Choi D, Park MJ: Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T. J Magn Reson Imaging 2014; 39: 1238–1245.LimSKimYKParkHJLeeWJChoiDParkMJ:Infiltrative hepatocellular carcinoma on gadoxetic acid-enhanced and diffusion-weighted MRI at 3.0T.2014;39:1238–1245.10.1002/jmri.2426524136725Search in Google Scholar
Halıloğlu N, Özkavukcu E, Erden A, Erden I: MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi. Turk J Gastroenterol 2011; 22: 158–164.HalıloğluNÖzkavukcuEErdenAErdenI:MR imaging in diffuse-type hepatocellular carcinoma with synchronous portal vein thrombi.2011;22:158–164.10.4318/tjg.2011.018521796552Search in Google Scholar
Park YS, Lee CH, Kim BH, Lee J, Choi JW, Kim KA et al.: Using Gd-EOBDTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis. Magn Reson Imaging 2013; 31: 1137–1142.ParkYSLeeCHKimBHLeeJChoiJWKimKA:Using Gd-EOBDTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.2013;31:1137–1142.10.1016/j.mri.2013.01.01123688409Search in Google Scholar
Rosenkrantz AB, Lee L, Matza BW, Kim S: Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity. Clin Radiol 2012; 67: e105–111.RosenkrantzABLeeLMatzaBWKimS:Infiltrative hepatocellular carcinoma: comparison of MRI sequences for lesion conspicuity.2012;67:105–111.10.1016/j.crad.2012.08.01923026725Search in Google Scholar
Choi JY, Lee JM, Sirlin CB: CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 2014; 273: 30–50.ChoiJYLeeJMSirlinCB:CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.2014;273:30–50.10.1148/radiol.14132362426377025247563Search in Google Scholar
Willatt JM, Hussain HK, Adusumilli S, Marrero JA: MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247: 311–130.WillattJMHussainHKAdusumilliSMarreroJA:MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.2008;247:311–130.10.1148/radiol.247206133118430871Search in Google Scholar
Dodd GD 3rd, Memel DS, Baron RL, Eichner L, Santiguida LA: Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus? AJR Am J Roentgenol 1995; 165: 573–577.DoddGD3rdMemelDSBaronRLEichnerLSantiguidaLA:Portal vein thrombosis in patients with cirrhosis: does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus?1995;165:573–577.10.2214/ajr.165.3.76454737645473Search in Google Scholar
Margini C, Berzigotti A: Portal vein thrombosis: The role of imaging in the clinical setting. Dig Liver Dis 2017; 49: 113–120.MarginiCBerzigottiA:Portal vein thrombosis: The role of imaging in the clinical setting.2017;49:113–120.10.1016/j.dld.2016.11.01327965037Search in Google Scholar
Tublin ME, Dodd GD 3rd, Baron RL: Benign and malignant portal vein thrombosis: differentiation by CT characteristics. AJR Am J Roentgenol 1997; 168: 719–723.TublinMEDoddGD3rdBaronRL:Benign and malignant portal vein thrombosis: differentiation by CT characteristics.1997;168:719–723.10.2214/ajr.168.3.90575229057522Search in Google Scholar
Raza SA, Jang HJ, Kim TK: Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound. Abdom Imaging 2014; 39: 153–161.RazaSAJangHJKimTK:Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound.2014;39:153–161.10.1007/s00261-013-0034-424002440Search in Google Scholar
Tarantino L, Ambrosino P, Di Minno MN: Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma. World J Gastroenterol 2015; 21: 9457–9460.TarantinoLAmbrosinoPDi MinnoMN:Contrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinoma.2015;21:9457–9460.10.3748/wjg.v21.i32.9457454810626327753Search in Google Scholar
Shah ZK, McKernan MG, Hahn PF, Sahani DV: Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions. AJR Am J Roentgenol 2007; 188: 1320–1323.ShahZKMcKernanMGHahnPFSahaniDV:Enhancing and expansile portal vein thrombosis: value in the diagnosis of hepatocellular carcinoma in patients with multiple hepatic lesions.2007;188:1320–1323.10.2214/AJR.06.013417449777Search in Google Scholar
Catalano OA, Choy G, Zhu A, Hahn PF, Sahani DV: Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging. Radiology 2010; 254: 154–162.CatalanoOAChoyGZhuAHahnPFSahaniDV:Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.2010;254:154–162.10.1148/radiol.0909030420032150Search in Google Scholar
Brancatelli G, Baron RL, Federle MP, Sparacia G, Pealer K: Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. AJR Am J Roentgenol 2009; 192: 1341–1347.BrancatelliGBaronRLFederleMPSparaciaGPealerK:Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT.2009;192:1341–1347.10.2214/AJR.07.278219380559Search in Google Scholar
Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Miller WJ, Campbell WL et al.: Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT. Radiology 1993; 188: 31–35.OhtomoKBaronRLDoddGD3rdFederleMPMillerWJCampbellWL:Confluent hepatic fibrosis in advanced cirrhosis: appearance at CT.1993;188:31–35.10.1148/radiology.188.1.85113168511316Search in Google Scholar
Ohtomo K, Baron RL, Dodd GD 3rd, Federle MP, Ohtomo Y, Confer SR: Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging. Radiology 1993; 189: 871–874.OhtomoKBaronRLDoddGD3rdFederleMPOhtomoYConferSR:Confluent hepatic fibrosis in advanced cirrhosis: evaluation with MR imaging.1993;189:871–874.10.1148/radiology.189.3.82347188234718Search in Google Scholar
Pokharel SS, Macura KJ, Kamel IR, Zaheer A. Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis. Radiographics 2013; 33: 681–702.PokharelSSMacuraKJKamelIRZaheerA.Current MR imaging lipid detection techniques for diagnosis of lesions in the abdomen and pelvis.2013;33:681–702.10.1148/rg.333125068Search in Google Scholar
Mortelé KJ, Segatto E, Ros PR: The infected liver: radiologic-pathologic correlation. Radiographics 2004; 24: 937–955.MorteléKJSegattoERosPR:The infected liver: radiologic-pathologic correlation.2004;24:937–955.10.1148/rg.244035719Search in Google Scholar
Chung YE, Kim MJ, Park YN, Choi JY, Pyo JY, Kim YC et al.: Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics 2009; 29: 683–700.ChungYEKimMJParkYNChoiJYPyoJYKimYC:Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation.2009;29:683–700.10.1148/rg.293085729Search in Google Scholar
Lee WJ, Lim HK, Jang KM, Kim SH, Lee SJ, Lim JH et al.: Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. Radiographics 2001; 21: S97–S116.LeeWJLimHKJangKMKimSHLeeSJLimJH:Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses.2001;21:S97–S116.10.1148/radiographics.21.suppl_1.g01oc12s97Search in Google Scholar
Shim M, Yang TY, Cho NG, Woo A, Kim E, Park K et al.: Hepatic infarction caused by portal vein thrombophlebitis misdiagnosed as infiltrative hepatic malignancy with neoplastic thrombus. Korean J Gastroenterol 2016; 68: 156–160.ShimMYangTYChoNGWooAKimEParkK:Hepatic infarction caused by portal vein thrombophlebitis misdiagnosed as infiltrative hepatic malignancy with neoplastic thrombus.2016;68:156–160.10.4166/kjg.2016.68.3.156Search in Google Scholar
Jüngst C, Kramer J, Schneider G, Lammert F, Zimmer V: Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration. Ann Hepatol 2013; 12: 834–836.JüngstCKramerJSchneiderGLammertFZimmerV:Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration.2013;12:834–836.10.1016/S1665-2681(19)31329-8Search in Google Scholar
Young ST, Paulson EK, Washington K, Gulliver DJ, Vredenburgh JJ, Baker ME: CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis. AJR Am J Roentgenol 1994; 163: 1385–1388.YoungSTPaulsonEKWashingtonKGulliverDJVredenburghJJBakerME:CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosis.1994;163:1385–1388.10.2214/ajr.163.6.79927347992734Search in Google Scholar
Jha P, Poder L, Wang ZJ, Westphalen AC, Yeh BM, Coakley FV: Radiologic mimics of cirrhosis. AJR Am J Roentgenol 2010; 194: 993–999.JhaPPoderLWangZJWestphalenACYehBMCoakleyFV:Radiologic mimics of cirrhosis.2010;194:993–999.10.2214/AJR.09.340920308502Search in Google Scholar
Ochiai T, Sonoyama T, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C et al.: Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol 2004; 130: 197–202.OchiaiTSonoyamaTIchikawaDFujiwaraHOkamotoKSakakuraC:Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis.2004;130:197–202.10.1007/s00432-003-0533-814770307Search in Google Scholar
Lopez RR Jr., Pan SH, Hoffman AL, Ramirez C, Rojter SE, Ramos H et al.: Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma. Arch Surg 2002; 137: 653–657; discussion 657–658.LopezRRJr.PanSHHoffmanALRamirezCRojterSERamosH:Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma.2002;137:653–657; discussion657–658.10.1001/archsurg.137.6.65312049535Search in Google Scholar
Jang ES, Yoon JH, Chung JW, Cho EJ, Yu SJ, Lee JH et al.: Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization. J Cancer Res Clin Oncol 2013; 139: 635–643.JangESYoonJHChungJWChoEJYuSJLeeJH:Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization.2013;139:635–643.10.1007/s00432-012-1364-223283527Search in Google Scholar
Kim SB: Diffuse infiltrative hepatocellular carcinoma with portal vein tumor thrombosis completely cured by transcatheter arterial chemoembolization: case report with 8-year follow-up. Case Rep Gastroenterol 2016; 10: 623–628.KimSB:Diffuse infiltrative hepatocellular carcinoma with portal vein tumor thrombosis completely cured by transcatheter arterial chemoembolization: case report with 8-year follow-up.2016;10:623–628.10.1159/000452208512157227920652Search in Google Scholar
Bruix J, Sherman M, American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020–1022.BruixJShermanM,American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: an update.2011;53:1020–1022.10.1002/hep.24199308499121374666Search in Google Scholar
Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF et al.: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378–390.LlovetJMRicciSMazzaferroVHilgardPGaneEBlancJF:Sorafenib in advanced hepatocellular carcinoma.2008;359:378–390.10.1056/NEJMoa070885718650514Search in Google Scholar
Kim HY, Park JW, Nam BH, Kim HK, Choi JI, Kim TH et al.: Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. J Gastroenterol Hepatol 2011; 26: 1612–1618.KimHYParkJWNamBHKimHKChoiJIKimTH:Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments.2011;26:1612–1618.10.1111/j.1440-1746.2011.06751.x21517968Search in Google Scholar
Mehta N, Fidelman N, Sarkar M, Yao FY: Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol 2013; 11: 572–578.MehtaNFidelmanNSarkarMYaoFY:Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.2013;11:572–578.10.1016/j.cgh.2012.12.030405289123333661Search in Google Scholar
Endo Y, Miyamoto M, Koujima T, Watanabe Y, Kawai T, Toda K et al.: [A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib]. Gan To Kagaku Ryoho 2012; 39: 963–965.EndoYMiyamotoMKoujimaTWatanabeYKawaiTTodaK:[A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib].2012;39:963–965.Search in Google Scholar
Ray EM, Sanoff HK: Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions. J Hepatocell Carcinoma 2017; 4: 131–138.RayEMSanoffHK:Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions.2017;4:131–138.10.2147/JHC.S124366568745329184856Search in Google Scholar
Marino D, Zichi C, Audisio M, Sperti E, Di Maio M: Second-line treatment options in hepatocellular carcinoma. Drugs Context 2019; 8: 212577.MarinoDZichiCAudisioMSpertiEDi MaioM:Second-line treatment options in hepatocellular carcinoma.2019;8:212577.10.7573/dic.212577646974531024634Search in Google Scholar
Personeni N, Pressiani T, Rimassa L: Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib. Future Oncol 2019; 15: 2449–2462.PersoneniNPressianiTRimassaL:Cabozantinib in patients with hepatocellular carcinoma failing previous treatment with sorafenib.2019;15:2449–2462.10.2217/fon-2019-002631204849Search in Google Scholar
Hsiao P, Hsieh KC, Chen YS, Hsu CC, Lo GH, Li YC et al.: Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma. Medicine (Baltimore) 2019; 98: e16074.HsiaoPHsiehKCChenYSHsuCCLoGHLiYC:Sorafenib with concurrent multiple-line therapies improves overall survival in advanced stage hepatocellular carcinoma.2019;98:16074.10.1097/MD.0000000000016074663696431232945Search in Google Scholar
Reghupaty SC, Sarkar D: Current status of gene therapy in hepatocellular carcinoma. Cancers (Basel) 2019; 11.ReghupatySCSarkarD:Current status of gene therapy in hepatocellular carcinoma.2019;11.10.3390/cancers11091265677084331466358Search in Google Scholar